Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Autologous Adipose Derived Mesenchymal Stem Cells (AD-MSCs) Therapy on Sexual Hormone Deficiency in the Middle-aged Patients: an Open-label, Single-group Clinical Trial

NCT03346967 is registered in ClinicalTrials.gov with Vinmec Research Institute of Stem Cell and Gene Technology as lead sponsor.

NCT NCT03346967
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03346967 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Autologous Adipose Derived Mesenchymal Stem Cells (AD-MSCs) Therapy on Sexual Hormone Deficiency in the Middle-aged Patients: an Open-label, Single-group Clinical Trial
Lead sponsor
Vinmec Research Institute of Stem Cell and Gene Technology
Phase
Phase 1/2
Overall status
Completed
Start date
November 1, 2017
Completion date
March 30, 2020
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hormone deficiency